famotidine has been researched along with Dermatitis Medicamentosa in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scheinfeld, N | 1 |
| Wesson, K | 1 |
| Perry, P | 1 |
| Weinberg, J | 1 |
| Warner, DM | 1 |
| Ramos-Caro, FA | 1 |
| Flowers, FP | 1 |
2 other studies available for famotidine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Acute generalized exanthematous pustulosis resembling toxic epidermal necrolysis caused by famotidine.
Topics: Diagnosis, Differential; Drug Eruptions; Exanthema; Famotidine; Female; Histamine H2 Antagonists; Hu | 2003 |
Famotidine (pepcid)-induced symptomatic dermatographism.
Topics: Adult; Drug Eruptions; Famotidine; Humans; Male; Middle Aged; Urticaria | 1994 |